| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | AU$ 124.67K | AU$ 161.16K | AU$ 125.05K | AU$ 91.98K | AU$ 145.90K |
| Gross Profit | AU$ 21.72K | AU$ -89.31K | AU$ -107.42K | AU$ -480.00K | AU$ -371.37K |
| Operating Income | AU$ -191.84M | AU$ -223.45M | AU$ -133.27M | AU$ -53.18M | AU$ -24.70M |
| EBITDA | AU$ -200.02M | AU$ -223.30M | AU$ -99.01M | AU$ -50.14M | AU$ -24.92M |
| Net Income | AU$ -220.24M | AU$ -211.88M | AU$ -127.99M | AU$ -60.79M | AU$ -16.12M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | AU$ 172.47M | AU$ 133.99M | AU$ 64.90M | AU$ 157.43M | AU$ 62.02M |
| Total Assets | AU$ 188.79M | AU$ 148.19M | AU$ 87.32M | AU$ 184.36M | AU$ 71.89M |
| Total Debt | AU$ 141.65M | AU$ 272.98K | AU$ 0.00 | AU$ 150.47K | AU$ 265.08K |
| Net Debt | AU$ -30.82M | AU$ -133.71M | AU$ -64.90M | AU$ -157.28M | AU$ -61.76M |
| Total Liabilities | AU$ 264.60M | AU$ 156.98M | AU$ 17.55M | AU$ 4.16M | AU$ 7.08M |
| Stockholders' Equity | AU$ -75.81M | AU$ -8.79M | AU$ 69.77M | AU$ 180.20M | AU$ 64.81M |
| Cash Flow | |||||
| Free Cash Flow | AU$ -161.05M | AU$ -179.34M | AU$ -98.39M | AU$ -61.08M | - |
| Operating Cash Flow | AU$ -161.02M | AU$ -179.30M | AU$ -98.37M | AU$ -61.06M | AU$ -8.24M |
| Investing Cash Flow | AU$ -33.49K | AU$ -32.64K | AU$ -23.32K | AU$ 880.07K | AU$ 482.83K |
| Financing Cash Flow | AU$ 243.73M | AU$ 248.70M | AU$ 236.62K | AU$ 156.76M | AU$ 48.06M |
Ceryvyn Therapeutics Limited (DE:UKJ2)
MUNICH:UKJ2
